3M Skin and Nasal Antiseptic: payments to doctors
Payments that named 3M Skin and Nasal Antiseptic as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $190K
- Providers
- 194
- Transactions
- 360
- Average per transaction
- $529
The per-transaction average — $529 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 194 providers the average total is $982, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Solventum Corporation | $112,029 | 58.8% |
| KCI USA, Inc. | $78,440 | 41.2% |